INDV (STOCKS)
Indivior Pharmaceuticals, Inc. Common Stock
$33.760000
-0.320000 (-0.94%)
Prev close: $34.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph J. Ciaffoni
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,212.57M
- Employees
- 1,051
- P/E (TTM)
- 33.61
- P/B (TTM)
- -20.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.72 | $0.42 | +0.3001 | +71.47% |
|
Jun 2025 (Q2)
|
$0.51 | $0.27 | +0.2448 | +92.31% |
|
Mar 2025 (Q1)
|
$0.41 | $0.24 | +0.1720 | +72.27% |
|
Dec 2024 (Q4)
|
$0.32 | $0.22 | +0.1007 | +45.92% |
Financial Statements
| Revenues | $1.13B |
| Benefits Costs and Expenses | $936.00M |
| Costs And Expenses | $928.00M |
| Operating Expenses | $726.00M |
| Selling, General, and Administrative Expenses | $620.00M |
| Other Operating Expenses | $106.00M |
| Operating Income/Loss | $227.00M |
| Income/Loss From Continuing Operations After Tax | $129.00M |
| Income/Loss From Continuing Operations Before Tax | $196.00M |
| Income Tax Expense/Benefit | $67.00M |
| Income Tax Expense/Benefit, Deferred | $29.00M |
| Net Income/Loss | $129.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $129.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $129.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.03 |
| Diluted Earnings Per Share | $1.01 |
| Assets | $1.42B |
| Current Assets | $922.00M |
| Inventory | $155.00M |
| Prepaid Expenses | $30.00M |
| Other Current Assets | $737.00M |
| Noncurrent Assets | $494.00M |
| Fixed Assets | $124.00M |
| Other Non-current Assets | $370.00M |
| Liabilities | $1.62B |
| Current Liabilities | $965.00M |
| Accounts Payable | $41.00M |
| Wages | $79.00M |
| Other Current Liabilities | $845.00M |
| Noncurrent Liabilities | $658.00M |
| Equity | -$207.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$207.00M |
| Liabilities And Equity | $1.42B |
| Net Cash Flow From Operating Activities | $177.00M |
| Net Cash Flow From Operating Activities, Continuing | $177.00M |
| Net Cash Flow | $191.00M |
| Net Cash Flow, Continuing | $191.00M |
| Comprehensive Income/Loss | $132.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $132.00M |
| Other Comprehensive Income/Loss | $111.00M |